申请人:Merck & Co., Inc.
公开号:US06399619B1
公开(公告)日:2002-06-04
The present invention is directed to pyrrolidine compounds of the formula I:
(wherein R1, R2, R3, R4, R5, R6 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.
本发明涉及公式I的吡咯烷化合物:(其中R1,R2,R3,R4,R5,R6和n在此定义),该化合物可用作趋化因子受体活性的调节剂。特别地,这些化合物可用作趋化因子受体CCR-5和/或CCR-3的调节剂。